Table of Content

Table of Contents

Global Psychoactive Substances Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Psychoactive Substances Market by Value
2.2.1 Global Psychoactive Substances Revenue by Type
2.2.2 Global Psychoactive Substances Market by Value (%)
2.3 Global Psychoactive Substances Market by Production
2.3.1 Global Psychoactive Substances Production by Type
2.3.2 Global Psychoactive Substances Market by Production (%)

3. The Major Driver of Psychoactive Substances Industry
3.1 Historical & Forecast Global Psychoactive Substances Demand
3.2 Largest Application for Psychoactive Substances (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Psychoactive Substances Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Psychoactive Substances Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Psychoactive Substances Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Psychoactive Substances Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Psychoactive Substances Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Psychoactive Substances Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Psychoactive Substances Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Psychoactive Substances Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Psychoactive Substances Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Psychoactive Substances Average Price Trend
12.1 Market Price for Each Type of Psychoactive Substances in US (2018-2022)
12.2 Market Price for Each Type of Psychoactive Substances in Europe (2018-2022)
12.3 Market Price for Each Type of Psychoactive Substances in China (2018-2022)
12.4 Market Price for Each Type of Psychoactive Substances in Japan (2018-2022)
12.5 Market Price for Each Type of Psychoactive Substances in India (2018-2022)
12.6 Market Price for Each Type of Psychoactive Substances in Korea (2018-2022)
12.7 Market Price for Each Type of Psychoactive Substances in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Psychoactive Substances Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Psychoactive Substances

14. Psychoactive Substances Competitive Landscape
14.1 Zynerba Pharmaceuticals
14.1.1 Zynerba Pharmaceuticals Company Profiles
14.1.2 Zynerba Pharmaceuticals Product Introduction
14.1.3 Zynerba Pharmaceuticals Psychoactive Substances Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 GW Pharmaceuticals PLC.
14.2.1 GW Pharmaceuticals PLC. Company Profiles
14.2.2 GW Pharmaceuticals PLC. Product Introduction
14.2.3 GW Pharmaceuticals PLC. Psychoactive Substances Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Enecta.
14.3.1 Enecta. Company Profiles
14.3.2 Enecta. Product Introduction
14.3.3 Enecta. Psychoactive Substances Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Teewinot Life Sciences
14.4.1 Teewinot Life Sciences Company Profiles
14.4.2 Teewinot Life Sciences Product Introduction
14.4.3 Teewinot Life Sciences Psychoactive Substances Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 GD Pharma
14.5.1 GD Pharma Company Profiles
14.5.2 GD Pharma Product Introduction
14.5.3 GD Pharma Psychoactive Substances Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Cape Bouvard Technologies Pty Ltd
14.6.1 Cape Bouvard Technologies Pty Ltd Company Profiles
14.6.2 Cape Bouvard Technologies Pty Ltd Product Introduction
14.6.3 Cape Bouvard Technologies Pty Ltd Psychoactive Substances Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 AusCann Group Holdings Pty Ltd.
14.7.1 AusCann Group Holdings Pty Ltd. Company Profiles
14.7.2 AusCann Group Holdings Pty Ltd. Product Introduction
14.7.3 AusCann Group Holdings Pty Ltd. Psychoactive Substances Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Cannabics Pharmaceuticals Inc.
14.8.1 Cannabics Pharmaceuticals Inc. Company Profiles
14.8.2 Cannabics Pharmaceuticals Inc. Product Introduction
14.8.3 Cannabics Pharmaceuticals Inc. Psychoactive Substances Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Alpha-CAT
14.9.1 Alpha-CAT Company Profiles
14.9.2 Alpha-CAT Product Introduction
14.9.3 Alpha-CAT Psychoactive Substances Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Tilray
14.10.1 Tilray Company Profiles
14.10.2 Tilray Product Introduction
14.10.3 Tilray Psychoactive Substances Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Cyrelian Pty Ltd.
14.12 MedReleaf Australia
15. Conclusion
16. Methodology and Data Source

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Psychoactive Substances Industry (Volume)
Figure 2. Psychoactive Substances Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Psychoactive Substances Revenue in 2022
Figure 5. US Psychoactive Substances Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Psychoactive Substances Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Psychoactive Substances Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Psychoactive Substances Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Psychoactive Substances Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Psychoactive Substances Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Psychoactive Substances Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Psychoactive Substances Revenue, by Type (Million USD) (2018-2028)
Table 4. Psychoactive Substances Production, by Type (K Unit) (2018-2028)
Table 5. Psychoactive Substances Demand (K Unit) by Application (2018-2028)
Table 6. Psychoactive Substances Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Psychoactive Substances Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Psychoactive Substances Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Psychoactive Substances Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Psychoactive Substances Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Psychoactive Substances Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Psychoactive Substances Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Psychoactive Substances Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Psychoactive Substances Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Psychoactive Substances in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Psychoactive Substances in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Psychoactive Substances in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Psychoactive Substances in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Psychoactive Substances in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Psychoactive Substances in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Psychoactive Substances in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Zynerba Pharmaceuticals Profiles
Table 61. Zynerba Pharmaceuticals Psychoactive Substances Product Introduction
Table 62. Zynerba Pharmaceuticals Psychoactive Substances Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Zynerba Pharmaceuticals Strategic initiatives
Table 64. GW Pharmaceuticals PLC. Profiles
Table 65. GW Pharmaceuticals PLC. Psychoactive Substances Product Introduction
Table 66. GW Pharmaceuticals PLC. Psychoactive Substances Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. GW Pharmaceuticals PLC. Strategic initiatives
Table 68. Enecta. Profiles
Table 69. Enecta. Psychoactive Substances Product Introduction
Table 70. Enecta. Psychoactive Substances Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Enecta. Strategic initiatives
Table 72. Teewinot Life Sciences Profiles
Table 73. Teewinot Life Sciences Psychoactive Substances Product Introduction
Table 74. Teewinot Life Sciences Psychoactive Substances Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Teewinot Life Sciences Strategic initiatives
Table 76. GD Pharma Profiles
Table 77. GD Pharma Psychoactive Substances Product Introduction
Table 78. GD Pharma Psychoactive Substances Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. GD Pharma Strategic initiatives
Table 80. Cape Bouvard Technologies Pty Ltd Profiles
Table 81. Cape Bouvard Technologies Pty Ltd Psychoactive Substances Product Introduction
Table 82. Cape Bouvard Technologies Pty Ltd Psychoactive Substances Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Cape Bouvard Technologies Pty Ltd Strategic initiatives
Table 84. AusCann Group Holdings Pty Ltd. Profiles
Table 85. AusCann Group Holdings Pty Ltd. Psychoactive Substances Product Introduction
Table 86. AusCann Group Holdings Pty Ltd. Psychoactive Substances Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. AusCann Group Holdings Pty Ltd. Strategic initiatives
Table 88. Cannabics Pharmaceuticals Inc. Profiles
Table 89. Cannabics Pharmaceuticals Inc. Psychoactive Substances Product Introduction
Table 90. Cannabics Pharmaceuticals Inc. Psychoactive Substances Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Cannabics Pharmaceuticals Inc. Strategic initiatives
Table 92. Alpha-CAT Profiles
Table 93. Alpha-CAT Psychoactive Substances Product Introduction
Table 94. Alpha-CAT Psychoactive Substances Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Alpha-CAT Strategic initiatives
Table 97. Tilray Profiles
Table 98. Tilray Psychoactive Substances Product Introduction
Table 99. Tilray Psychoactive Substances Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Tilray Strategic initiatives
Table 101. Cyrelian Pty Ltd. Profiles
Table 102. Cyrelian Pty Ltd. Psychoactive Substances Product Introduction
Table 103. Cyrelian Pty Ltd. Psychoactive Substances Production (Unit), Revenue (Million USD) (2018-2022)
Table 104. Cyrelian Pty Ltd. Strategic initiatives
Table 105. MedReleaf Australia Profiles
Table 106. MedReleaf Australia Psychoactive Substances Product Introduction
Table 107. MedReleaf Australia Psychoactive Substances Production (Unit), Revenue (Million USD) (2018-2022)
Table 108. MedReleaf Australia Strategic initiatives